Business News Archives - Pendopharm

Business News

August 27, 2021

Health Canada Approves MYINFLA^TM (Colchicine 0.5 mg Extended-Release Tablets), a New Repurposed Treatment for Cardiovascular Disease

November 16, 2019

Pharmascience inc. contributes to the Montreal Heart Institute’s Colchicine Cardiovascular Outcome Trial (COLCOT)

November 12, 2018

PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award

February 20, 2018

PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals

September 22, 2017

PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada